AlzChem Group AG

Andreas Niedermaier becomes new CEO – Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019

Trostberg, June 3, 2019 – The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view of the resignation of the current CEO Mr. Ulli Seibel as of December 31, 2019. In this function, Mr. Niedermaier will also be responsible for Investor Relations and Communications. Dr. Georg Weichselbaumer was newly appointed to the Management Board effective July 1, 2019. Dr.

AlzChem Group AG: Annual General Meeting approves dividend of EUR 0.09 per share

Trostberg, May 14, 2019 – At today's Annual General Meeting of AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, the shareholders present honored the successful business development and corporate strategy and expressed their confidence in the Management Board and Supervisory Board. All items on the agenda were resolved by a large majority in the interests of management, which included a dividend payment of EUR 0.09 per share and, among other things, a reverse stock split of 10 to 1.

Majority shareholders considering to increase free-float significantly in the near term

Our three majority shareholders today informed us about their intention to significantly increase AlzChem Group AG’s free-float by offering shares from their holdings in the near term. A decision on the exact size, structure and timing of such a potential placement has not been taken yet and will be communicated at a later time. In this respect, the three majority shareholders are being advised by Berenberg.